miRNA in Patients With Thoracic, Abdominal and Intracranial Aneurysms
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 35
- 试验地点
- 1
- 主要终点
- The comparison of miRNA in healthy and aneurysmatic tissue
研究概览
简要总结
To assess the expression of miRNA in patients with TAA, AAA in aneurysmatic tissue and to compare this expression with the healthy tissue in the same patient.
In the same cohort, to asses the presence of miRNA in plasma and to compare with the control group.
Over the period of three years,to follow subjects in order to assess if the presence of certain miRNAs speeds up or slows down the progression of disease.
In patients with intracranial aneurysms to detect miRNA in plasma especially in patients with familial occurrence.
详细描述
MicroRNAs constitute a recently discovered class of non-coding RNAs that play key roles in the regulation of gene expression. Acting at the post-transcriptional level, MicroRNAs have been shown to be involved in a wide range of biological processes such as cell cycle control, apoptosis and several developmental and physiological processes including stem cell differentiation, hematopoiesis, hypoxia, cardiac and skeletal muscle development. In addition to their important roles in healthy individuals, microRNAs have also been implicated in a number of diseases including a broad range of cancers, cardiovascular and heart disease. Their different expression in aortic tissue in patients with aortic abdominal aneurysm and their association with the progression of the disease were confirmed. They represent the potential target for the treatment of the disease. MiRNA act as biomarkers showing the potential risk of the presence of TAA, AAA and intracranial aneurysm, for the prediction of TAA and AAA progression and for the discovery of new treatment possibilities.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 80 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •18 years of age or older
- •Patient willing and able to sign clinical trial Informed Consent
- •Patient with AAA or TAA who require an open surgical procedure, or patient with intracranial aneurysm indicated for radiological intervention
排除标准
- •Patient with multiorgan failure
结局指标
主要结局
The comparison of miRNA in healthy and aneurysmatic tissue
时间窗: 2020 at end of trial
miRNA will be compared in blood and in healthy and aneurysmatic tissue using ngs
次要结局
未报告次要终点
研究者
Assoc. Prof. Miroslav Prucha, M.D., PhD.
Assoc.Prof
Na Homolce Hospital
